FDA greenlights Abbott's wearable sensor for capturing diabetic ketoacidosis

The FDA has cleared Abbott's Libre Duo 10 Day, the first wearable sensor that monitors both glucose and ketone levels to warn diabetics of potential diabetic ketoacidosis, with availability in the U.S. expected later this year.

This Wire brief sits within Fusion42's coverage of Medtech, and 7 sources have reported it between 25 Aug 2026 and 27 Aug 2026.